(4-甲基-2-(苯基甲氧基)苯基)乙酸 | 117571-37-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: (4-甲基-2-(苯基甲氧基)苯基)乙酸
• 英文名称: <4-methyl-2-(phenylmethoxy)phenyl>acetic acid
• 英文别名: 2-(2-(benzyloxy)-4-methylphenyl)acetic acid；(4-methyl-2-phenylmethoxyphenyl)acetic acid；2-(4-methyl-2-phenylmethoxyphenyl)acetic acid
• CAS: 117571-37-6
• 化学式: C₁₆H₁₆O₃
• 分子量: 256.301
• InChiKey: AYOWIBCOOKQTQC-UHFFFAOYSA-N

物化性质

• 熔点：
  77-80 °C(Solv: methanol (67-56-1))
• 沸点：
  423.3±35.0 °C(Predicted)
• 密度：
  1.176±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (4-甲基-2-(苯基甲氧基)苯基)乙酸 在 钯 作用下， 以 乙醇 为溶剂， 以to give (2-hydroxy-4-methylphenyl)acetic acid的产率得到2-羟基-4-甲基苯乙酸
  参考文献：
  名称：

  Compounds having antitumor and antibacterial properties

  摘要：

  通式（I）所代表的新型黄色素-4-乙酸类化合物，其中R.sub.1代表以下任意一个或两个基团：低碳链烷基，卤素，CF.sub.3，CN，NO.sub.2，NH.sub.2，CH.sub.2 COOH，OR.sub.2，OH，NHCOR.sub.2，NHSO.sub.2 R.sub.2，SR.sub.2，SO.sub.2 R.sub.2，CH.sub.2 CONHR.sub.2或NHR.sub.2（其中R.sub.2为低碳链烷基，可选地带有羟基，氨基或甲氧基功能），在可用的1-8位置中的任意位置。R.sub.1还可以代表将一个或两个亚胺（-N.dbd.）基团取代为碳环中的一个或两个甲烷（-CH.dbd.）基团，而在任意两个可用的相邻位置上的两个R.sub.1也可以代表群-CH.dbd.CH-CH.dbd.CH-以形成额外的融合苯环;以及其基本加成盐，具有抗肿瘤和抗菌性能。

  公开号：

  US05281620A1
• 作为产物：
  描述：

  4-甲基水杨酸 在 sodium hydroxide 、 sodium tetrahydroborate 、 氯化亚砜 、 四丁基溴化铵 、 三溴化磷 、 N,N-二甲基甲酰胺 作用下， 以 乙醇 、 二氯甲烷 、 二乙二醇二甲醚 、 水 、 苯 为溶剂， 反应 20.17h， 生成 (4-甲基-2-(苯基甲氧基)苯基)乙酸
  参考文献：
  名称：

  Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo

  摘要：

  In a search for compounds related to flavoneacetic acid with activity against solid tumors, a series of methyl-, methoxy-, chloro-, nitro-, and hydroxy-substituted xanthenone-4-acetic acids have been synthesized and evaluated against subcutaneously implanted colon adenocarcinoma 38 in vivo, using a short-term histology assay as a primary screening system. A major goal of this work was to identify compounds with similar profiles of activity to that of flavoneacetic acid but of higher potency. The level of activity of the compounds appeared to depend more on the nature of the substituent than its positioning, in the order Cl greater than Me, OMe greater than NO2, OH. However, the potency of the compounds was related much more to the position rather than the nature of the substitution, with 5-substituted compounds being clearly the most dose potent. 5-Methylxanthenone-4-acetic acid has a similar level of activity to that of flavoneacetic acid in the test systems employed but is more than 7-fold as dose potent.

  DOI：

  10.1021/jm00124a012

文献信息

• Compounds having antitumor and antibacterial properties
  申请人：Cancer Research Campaign Technology Limited

  公开号：US05281620A1

  公开（公告）日：1994-01-25

  The novel class of xanthenone-4-acetic acids represented by the general formula (I) ##STR1## where R.sub.1 represents up to two of the groups lower alkyl, halogen, CF.sub.3, CN, NO.sub.2, NH.sub.2, CH.sub.2 COOH, OR.sub.2, OH, NHCOR.sub.2, NHSO.sub.2 R.sub.2, SR.sub.2, SO.sub.2 R.sub.2, CH.sub.2 CONHR.sub.2 or NHR.sub.2 (where R.sub.2 is lower alkyl optionally substituted with hydroxy, amino or methoxy functions), at any of the positions 1-8 which are available, R.sub.1 may also represent the substitution of an aza (--N.dbd.) group for one or two of the methine (--CH.dbd.) groups in the carbocyclic rings and two of R.sub.1 on any two available adjacent positions may also represent the grouping --CH.dbd.CH--CH.dbd.CH-- to form an additional fused benzene ring; and basic addition salts thereof, possess antitumour and antibacterial properties.

  新型黄色酮-4-乙酸类化合物的一般式(I)如下：其中R.sub.1代表最多两个以下的基团：低碳烷基、卤素、三氟甲基、氰基、硝基、氨基、甲基羧基、OR.sub.2、羟基、NHCOR.sub.2、NHSO.sub.2 R.sub.2、SR.sub.2、SO.sub.2 R.sub.2、CH.sub.2 CONHR.sub.2或NHR.sub.2（其中R.sub.2是低碳烷基，可选择地被羟基、氨基或甲氧基取代），在可用的1-8位置中的任何位置，R.sub.1也可以代表在碳环中的一个或两个亚甲基（--CH.dbd.）基团被一个氮杂基(--N.dbd.)取代，而且在任意两个相邻位置上的两个R.sub.1也可以代表--CH.dbd.CH--CH.dbd.CH--的基团，形成一个额外的融合苯环；以及其碱性加盐，具有抗肿瘤和抗菌特性。
• Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids
  作者：Gordon W. Rewcastle、Graham J. Atwell、Li Zhuang、Bruce C. Baguley、William A. Denny

  DOI：10.1021/jm00105a034

  日期：1991.1

  Analogues of 9-oxo-9H-xanthene-4-acetic acid (XAA) bearing small, lipophilic 5-substituents are among the most dose-potent compounds yet reported with the capability of causing hemorrhagic necrosis of implanted colon 38 tumors in mice. To further extend structure-activity relationships among this class of compound, a series of XAA derivatives bearing two small lipophilic groups at various positions

  带有小的，亲脂性的5个取代基的9-氧代9H-氧杂蒽-4-乙酸（XAA）的类似物是迄今已报道的最强剂量化合物，具有引起小鼠植入的结肠38肿瘤出血性坏死的能力。为了进一步扩展这类化合物之间的构效关系，已经制备并评估了一系列在不同位置带有两个小的亲脂基团的XAA衍生物。特别是5，6-二取代的化合物始终显示出高水平的剂量效力和活性，这表明这是取代的9-氧代-9H-氧杂蒽-4-乙酸中的最佳构型。5,6-二甲基和5-甲基-6-甲氧基是最有效的类似物，
• MEDICARPIN, ITS DERIVATIVES, MANUFACTURING METHOD THEREOF
  申请人：PhytoHealth Corporation

  公开号：US20180086772A1

  公开（公告）日：2018-03-29

  A compound and a method thereof are provided. The compound of the invention has formula I shown below. Each variable in formula I and manufacturing method are defined in the specification. The invention also provides a method for treating organ dysfunction.

  本发明提供了一种化合物及其制备方法。该发明的化合物具有下式I所示的公式。公式I中的每个变量和制备方法在说明书中定义。本发明还提供了一种治疗器官功能障碍的方法。
• Phenylalanine derivatives
  申请人：United States of America, represented by the Secretary, Department of Health and Human Services

  公开号：US07226991B1

  公开（公告）日：2007-06-05

  Disclosed herein are phenylalanine derivative compounds of the following formula W—Y—(AA)n—Z wherein Y is a phenylalanyl radical, AA is an amino acid, n is an integer of 1 to 15, and substituent variables W and Z are as described herein. The compounds can be used to inhibit SH2 binding with phosphoproteins, and to inhibit proliferation of tumor cells.

  本文公开了以下式子的苯丙氨酸衍生物化合物W—Y—(AA)n—Z，其中Y是苯丙氨酰基，AA是氨基酸，n是1到15的整数，取代变量W和Z如本文所述。这些化合物可用于抑制SH2与磷酸化蛋白的结合，并抑制肿瘤细胞的增殖。
• PHENYLALANINE DERIVATIVES
  申请人：Burke R. Terrence

  公开号：US20070219194A1

  公开（公告）日：2007-09-20

  The present invention provides phenylalanine derivatives that inhibit SH2 domain binding with a phosphoprotein. These derivatives include compounds of the formula: W—Y-(AA) n -Z wherein n is 0 to 15; Y is a phenylalanyl radical having a phenyl ring, an amine end, and a carboxyl end, the phenyl ring having one or more substituents, e.g., hydroxyl, carboxyl, formyl, carboxyalkyl, carboxyalkyloxy, dicarboxyalkyl, dicarboxyalkyloxy, dicarboxyhaloalkyl, dicarboxyhaloalkyloxy, and phosphonoalkyl, or phosphonohaloalkyl; W is a moiety attached to the nitrogen of Y and is, e.g., alkylcarbonyl, oxalyl, alkylaminooxalyl, arylaminooxalyl, arylalkylaminooxalyl, or alkoxyoxalyl; AA is an amino acid, the amine end of which is attached to the carboxyl end of Y; and Z is an arylalkylamino or arylheterocyclyl alkylamino; or a salt thereof; with the proviso that W is not arylalkylamino when the phenyl ring of phenylalanyl contains a phosphonoalkyl or phosphonohaloalkyl substituent at a position para to the alkylamido group and the ortho and meta positions are unsubstituted. The present invention further provides precursors suitable for preparing the phenylalanine derivatives and a method for the preparation of the precursors. The present invention further provides conjugates comprising a precursor and a conjugant that are covalently linked. These conjugates have biological and/or pharmacological properties.

  本发明提供苯丙氨酸衍生物，其抑制SH2域与磷酸化蛋白结合。这些衍生物包括以下公式的化合物：W—Y-(AA)n-Z，其中n为0至15；Y是具有苯环、胺端和羧基端的苯丙氨酰基基团，苯环具有一个或多个取代基，例如羟基、羧基、甲酰基、羧基烷基、羧基烷氧基、二羧基烷基、二羧基烷氧基、二羧基卤代烷基、二羧基卤代烷氧基、磷酸烷基或磷酸卤代烷基；W是连接到Y的氮上的基团，例如烷基羰基、草酰基、烷基氨基草酰基、芳基氨基草酰基、芳基烷基氨基草酰基或烷氧基草酰基；AA是一种氨基酸，其胺端连接到Y的羧基端；Z是芳基烷基氨基或芳基杂环基烷基氨基；或其盐；但是，当苯丙氨酰基的苯环在烷基酰基基团的对位上含有磷酸烷基或磷酸卤代烷基取代基，并且邻位和间位未取代时，W不是芳基烷基氨基。本发明还提供适用于制备苯丙氨酸衍生物的前体以及制备前体的方法。本发明还提供共价连接的前体和结合物的共轭物。这些共轭物具有生物和/或药理学性质。